Clinical trial: Treating poorly controlled asthma

(National Institutes of Health) UPDATED 2008-09-05

In this Phase II clinical trial, researchers will study the safety and effectiveness of the drug reslizumab in patients who have poorly controlled asthma. This national study is currently recruiting non-smoking asthmatics between the ages of 18 and 75.

Read full story >

See all Allergy News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Clinical trial: Treating poorly controlled asthma

People who read this also read...

What the community is saying...

Q & A on Drug Reactions: Was it an Allergic or Non-Allergic Type of Reaction?

James Thompson, MD